Acute coronary syndrome (ACS) poses a signifcant burden worldwide; however, the development of high-sensitivity cardiac troponin (hs-cTn) assays has greatly improved patient management by enabling the detection of very low levels of troponin. The objective of this review was to identify current hs-cTn point-of-care (POC) assays, describe their key features, and discuss their analytical and clinical performance

The Global Sepsis Alliance is pleased to announce a special World Sepsis Congress Satellite Session on Antimicrobial Stewardship and Sepsis, taking place online on November 27, 2025, from 15:00 to 16:30 CET. Participation is free of charge, and healthcare professionals, policymakers, researchers, students, and advocates are warmly invited to register for free below.

This booklet aims to guide healthcare professionals through the process of developing and implementing a successful Antimicrobial Stewardship Program (ASP) in their hospital. The pragmatic “ASP Building Blocks” approach used in the booklet makes it a truly ‌“hands-on” resource and a must-read for ASP teams.

Explore essential strategies on drug dosing, Minimum Inhibitory Concentration (MIC), and therapeutic monitoring to improve patient care.

Join leading clinicians, researchers, and AMR experts for two powerful days of knowledge-sharing and connection. Empowered by bioMérieux Canada, the AMR

Rapid multiplex point-of-care (POC) PCR tests may reduce unnecessary antibiotic prescribing by quickly identifying viral etiologies in patients with acute respiratory infections (ARI). We evaluated the impact of a rapid (~15 min) multiplex PCR test on antibiotic prescribing, provider confidence, patient satisfaction, and emergency department (ED) length of stay (LOS).

An official journal of the Infectious Diseases Society of America. Publishes clinical, translational, and basic research findings focusing on the intersection of biomedical science and clinical practice.

With an ever-expanding portfolio of FDA-cleared devices for rapid AST directly from positive blood cultures, microbiology laboratories have more choices than ever.

One in six laboratory-confirmed bacterial infections causing common infections in people worldwide in 2023 were resistant to antibiotic treatments, according to a new World Health Organization (WHO) report launched today.

US infections caused by New Delhi metallo-β-lactamase–producing carbapenem-resistant Enterobacterales (NDM-CRE) increased by more than 460% from 2019 to 2023, according to a Centers for Disease Control and Prevention (CDC) analysis published in the Annals of Internal Medicine.1-2 The agency warns that limited access to carbapenemase testing is hindering detection, delaying targeted therapy, and likely undercounting the true burden. To explore the diagnostics angle, and how faster, broader testing can strengthen stewardship, John Osiecki, PhD, vice president, medical affairs in North America at bioMérieux, spoke to Contagion on this significant need.

bioMérieux collaborates with Henry Ford Health to host a summit tackling the escalating threat of antimicrobial resistance, uniting healthcare leaders to promote effective diagnostics and stewardship.

This event will be chaired by Professor Angharad Davies, RCPath Clinical Director for Publishing and Engagement. A Q&A will follow the talks.

SPONSORED: Check out the new podcast by ID:IOTS with HIS Corporate Partners bioMérieux. Chloe Pinkney, Clinical Development Specialist, joins ID:IOTS podcast to talk about the launch of LUMED™ APSS™, a Clinical Decision Support System (CDSS) and how it is transforming Antimicrobial Stewardship by: 👉Identifying non-optimal antibiotic prescriptions 👉Supporting evidence-based treatment decisions 👉Reducing IV use and hospital stays 👉Enhancing patient safety and outcomes Listen now 🔗 https://lnkd.in/eJ8N_Khh